Skip to content

Chronic Pain in Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer

Unknown statusNCT00971919
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

RATIONALE: Learning about chronic pain in women who have undergone surgery for breast cancer may help improve the quality of life for these patients and may help doctors plan the best treatment. PURPOSE: This clinical trial is studying chronic pain in women who have undergone surgery for stage I, stage II, or stage III breast cancer.

Study details

Official title
Prospective Cohort Study to Investigate Chronic Pain After Breast Cancer Surgery
Conditions
Sponsor
Aberdeen Royal Infirmary
Organization
National Cancer Institute (NCI)
Start date
2007-03
Primary completion
2010-05
Sex
Female
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
United Kingdom
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
DISEASE CHARACTERISTICS: * Histologically confirmed invasive breast cancer or carcinoma in situ of the breast by core biopsy or fine needle aspiration * Newly diagnosed disease * Stage I-III disease * Resectable disease * Being treated in the Aberdeen, Dundee, Perth, or Inverness Breast Unit * Planning to undergo primary surgical excision of the tumor (e.g., breast conservation surgery or mastectomy with or without axillary surgery \[sentinel node biopsy, axillary sample, or axillary clearance\]) * Planning to undergo standard adjuvant therapy after surgery, including radiotherapy, chemotherapy, and/or hormonal therapy, as per existing standard protocols * No detectable metastatic disease PATIENT CHARACTERISTICS: * Not pregnant * Speaks English * No history of mental illness PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00971919